Sprott Inc.
- SEC CIK
- 0001512920
- Latest filing
- Jul 28, 2026
IKT holding history
Inhibikase Therapeutics, Inc. in every 13F filed by Sprott Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IKT overviewAll 13F holders of IKTFull Q2 2026 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 1
- Since Q4 2022